SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-22-001570
Filing Date
2022-02-14
Accepted
2022-02-14 16:01:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9177455_13g-a.htm SC 13G/A 128348
  Complete submission text file 0000919574-22-001570.txt   129967
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 22631117
SIC: 2834 Pharmaceutical Preparations

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

IRS No.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A